CClinicalTrials.gg
Status unknownNCT05659511Updated Jan 4, 2023

Study on Cognitive Impairment of Insomnia Based on MRI

An observational study in Insomnia, Cognitive Disorder and MRI, sponsored by Tang-Du Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-04.

Sponsored by Tang-Du Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
684
Ages
18 Years and older
Sex
All
01

Study summary

Insomnia is a common sleep disorder. In recent years, the incidence of insomnia is increasing worldwide. Studies point out that insomnia plays an important role in the pathogenesis of cognitive impairment. Although sleep and cognitive scales are the main methods to detect sleep quality and cognitive changes, there are problems such as strong subjectivity and poor repetition. There is an urgent need to use non-invasive and objective detection methods to assess the potential mechanisms of cognitive impairment caused by sleep disorders. Previous studies have shown that different brain states may show different neurovascular coupling (NVC) characteristics. However, after prolonged sleep deprivation, the evoked hemodynamics response was attenuated despite an increased electroencephalogram (EEG) signal response, suggesting that sustained neural activity may reduce vascular compliance. It is suggested that sleep disorder may lead to NVC disorder. However, whether sleep disorders regulate the mechanism of cognitive impairment in the brain through NVC disorders has not been demonstrated in vivo. Currently, functional magnetic resonance imaging (fMRI) can be used to study brain function and blood flow changes non-invasively. In our previous research, we combined cerebral blood flow (CBF) with mean amplitude of low-frequency fluctuation (mALFF), mean regional homogeneity (mReHo) and degree-centrality (DC), the early warning effect of fMRI features based on neurovascular uncoupling on early cognitive impairment was confirmed, providing a basis for further selection of functional imaging indicators. In conclusion, the present study proposes the scientific hypothesis that neurovascular decoupling-based MRI features are more appropriate for exploring the neural mechanisms underlying sleep disorders-induced brain cognitive impairment. The aim of this study is to establish an early warning and monitoring system for early non-invasive diagnosis and intervention of sleep-related cognitive impairment.

02

Conditions studied

03

In context

Sleep Initiation and Maintenance Disorders

1,856 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 594 are open to participants now.

This study's planned enrollment of 684 is above the median of 128 across 191 observational studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Tang-Du Hospital is the lead sponsor of 164 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

insomnia

Inclusion criteria

  • Sleep score meets the group standard
  • Education time more than 8 years
  • Without dementia
  • Inform Consent Form

Exclusion criteria

Exclusion Criteria:

  • Pregnant woman
  • Suffer from serious brain disease
  • Magnetic resonance contraindications
  • Image quality is too poor to deal with
  • Lack of compliance
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
684 participants (estimated)
Patient registry
No

Groups and cohorts

  • healthy control group

    Healthy people neither in insomnia group nor in MCI group.

    Diagnostic Test: MRI

  • insomnia

    Pittsburgh sleep quality index (PSQI)\>5, Epworth Sleepiness Scale (ESS)\>9 ,Insomnia Severity Index (ISI)\>8.

    Diagnostic Test: MRI

  • insomnia-MCI

    Pittsburgh sleep quality index(PSQI)\>5 ,Epworth Sleepiness Scale(ESS)\>9 ,Insomnia Severity Indeex(ISI)\>8; 20\< MoCA\<26.

    Diagnostic Test: MRI

Interventions

  • Diagnostic testMRI

    MRI data was acquired with a GE discovery MR750 3.0 T scanner using an eight-channel phased- array head coil. Foam padding was used to restrict head movement and ear plugs were used to eliminate scanner noise. During the acquisition period, all participants were asked to keep their eyes closed and not to think anything.

06

What researchers measure

Primary outcomes

  1. Screening out early warning indicators of MCI in patients with insomnia

    Based on the neurovascular uncoupled MRI features and imaging omics features of ID patients with MCI, the early warning indicators of MCI in ID patients were screened by machine learning algorithm.

    Time frame: baseline

Secondary outcomes

  1. Construct an automatic and individualized accurate diagnosis model for insomnia with MCI

    The structural MRI and functional MRI were used to analyze the biological changes or other mechanisms related to sleep disorders, and the clinical information and neuroimaging characteristics were combined to initially build an automatic and individualized accurate diagnostic model for insomnia and MCI with sensitivity, specificity and accuracy\>80%.

    Time frame: through study completion, an average of 2 year

07

Study locations

1 of 1 sites recruiting
  • Tangdu Hospital
    Xi'an, Shaanxi 710032, China
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05659511
Lead sponsor
Tang-Du Hospital
Responsible party
Sponsor
First posted
Dec 21, 2022
Start date
Jul 1, 2022
Primary completion
Jun 30, 2023 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Jan 4, 2023

Study contacts

Lin-Feng Yan
Contact
ylf8342@163.com
029-18691899018
Ying Yu
Contact
yqlmn@126.com
029-18191260958

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion